102 related articles for article (PubMed ID: 1689930)
1. [Clinical study of urinary cytology in bladder tumors--analysis of factors related with positivity of urinary cytology].
Tanaka K; Takashi M; Sahashi M; Shimoji T; Miyake K; Koshikawa T; Shiral T; Kawashima K; Nakajima N; Hamajima N
Hinyokika Kiyo; 1990 Jan; 36(1):7-11. PubMed ID: 1689930
[TBL] [Abstract][Full Text] [Related]
2. Suspicious urine cytology (class III) in patients with bladder cancer: should it be considered as negative or positive?
Raitanen MP; Aine RA; Kaasinen ES; Liukkonen TJ; Kylmälä TM; Huhtala H; Tammela TL;
Scand J Urol Nephrol; 2002; 36(3):213-7. PubMed ID: 12201938
[TBL] [Abstract][Full Text] [Related]
3. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
4. [Urinary cytology for carcinoma of the urinary bladder].
Nagumo S; Matuda M; Kuroda M
Rinsho Byori; 1992 Jul; 40(7):728-35. PubMed ID: 1507491
[TBL] [Abstract][Full Text] [Related]
5. Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study.
Pfister C; Chautard D; Devonec M; Perrin P; Chopin D; Rischmann P; Bouchot O; Beurton D; Coulange C; Rambeaud JJ
J Urol; 2003 Mar; 169(3):921-4. PubMed ID: 12576813
[TBL] [Abstract][Full Text] [Related]
6. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
7. [Voided urinary cytodiagnosis. Cyto-histologic comparison].
Zerat L; Fontanière B; Claude JM; Potet F; Verges J
Ann Urol (Paris); 1988; 22(4):249-53. PubMed ID: 3190165
[TBL] [Abstract][Full Text] [Related]
8. Voided urinary cytology in bladder cancer: is it time to review the indications?
Talwar R; Sinha T; Karan SC; Doddamani D; Sandhu A; Sethi GS; Srivastava A; Narang V; Agarwal A; Adhlakha N
Urology; 2007 Aug; 70(2):267-71. PubMed ID: 17826487
[TBL] [Abstract][Full Text] [Related]
9. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
Raitanen MP; Aine R; Kylmälä T; Kallio J; Liukkonen T; Tammela T;
Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413
[TBL] [Abstract][Full Text] [Related]
10. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
11. [Urine cytology as a supplement to cystoscopy and biopsy in the control of bladder tumors].
Andersen OP; Ladefoged C; Røhl HF; Osther P; Holm K
Ugeskr Laeger; 1989 Dec; 151(50):3400-1. PubMed ID: 2609449
[TBL] [Abstract][Full Text] [Related]
12. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study on urinary cytology in renal pelvic and ureteral tumors].
Igarashi H; Ohishi Y; Onodera S; Ohnishi T; Yamazaki H; Tomita M; Tashiro K
Hinyokika Kiyo; 1996 Jul; 42(7):493-6. PubMed ID: 8809556
[TBL] [Abstract][Full Text] [Related]
14. Comparison of screening methods in the detection of bladder cancer.
Ramakumar S; Bhuiyan J; Besse JA; Roberts SG; Wollan PC; Blute ML; O'Kane DJ
J Urol; 1999 Feb; 161(2):388-94. PubMed ID: 9915409
[TBL] [Abstract][Full Text] [Related]
15. [Identification of factors conditioning urinary cytology in bladder cancer].
Páez Borda A; Luján Galán M; Martín Osés E; Bustamante Alarma S; Romero Cagigal I; Coba Ceballos JM; Berenguer Sánchez A
Arch Esp Urol; 1996 Sep; 49(7):693-9. PubMed ID: 9020006
[TBL] [Abstract][Full Text] [Related]
16. [Clinicopathological study of urinary bladder tumors. Clinical evaluation of immunohistochemistry in urine cytology].
Nagata Y; Kinoshita H; Kawamura N; Sasadaira S
Hinyokika Kiyo; 1985 Nov; 31(11):1931-7. PubMed ID: 4091136
[TBL] [Abstract][Full Text] [Related]
17. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
[TBL] [Abstract][Full Text] [Related]
19. The role of urinary cytology for detection of bladder cancer.
Planz B; Jochims E; Deix T; Caspers HP; Jakse G; Boecking A
Eur J Surg Oncol; 2005 Apr; 31(3):304-8. PubMed ID: 15780568
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
